ELAN
Income statement / Annual
Last year (2024), Elanco Animal Health Incorporated's total revenue was $4.44 B,
an increase of 0.50% from the previous year.
In 2024, Elanco Animal Health Incorporated's net income was $338.00 M.
See Elanco Animal Health Incorporated,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$4.44 B |
$4.42 B |
$4.41 B |
$4.76 B |
$3.27 B |
$3.07 B |
$3.07 B |
$2.89 B |
$2.91 B |
$2.91 B |
| Cost of Revenue |
$2.53 B
|
$2.48 B
|
$2.44 B
|
$2.69 B
|
$2.03 B
|
$1.67 B
|
$1.77 B
|
$1.72 B
|
$1.58 B
|
$1.70 B
|
| Gross Profit |
$1.91 B
|
$1.94 B
|
$1.97 B
|
$2.08 B
|
$1.25 B
|
$1.40 B
|
$1.30 B
|
$1.17 B
|
$1.33 B
|
$1.21 B
|
| Gross Profit Ratio |
0.43
|
0.44
|
0.45
|
0.44
|
0.38
|
0.46
|
0.42
|
0.41
|
0.46
|
0.42
|
| Research and Development Expenses |
$344.00 M
|
$327.00 M
|
$321.00 M
|
$369.00 M
|
$327.00 M
|
$270.10 M
|
$246.60 M
|
$251.70 M
|
$265.80 M
|
$291.00 M
|
| General & Administrative Expenses |
$1.07 B
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$236.00 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$1.31 B
|
$1.29 B
|
$1.27 B
|
$1.40 B
|
$996.60 M
|
$760.20 M
|
$735.20 M
|
$779.80 M
|
$784.80 M
|
$916.00 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$1.66 B
|
$1.61 B
|
$1.59 B
|
$1.77 B
|
$1.32 B
|
$1.03 B
|
$981.80 M
|
$1.03 B
|
$1.05 B
|
$1.21 B
|
| Cost And Expenses |
$4.19 B
|
$4.09 B
|
$4.03 B
|
$4.46 B
|
$3.35 B
|
$2.70 B
|
$2.75 B
|
$2.75 B
|
$2.63 B
|
$2.90 B
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$339.00 M
|
$277.00 M
|
$256.00 M
|
$264.00 M
|
$156.00 M
|
$78.90 M
|
$29.60 M
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$662.00 M
|
$694.00 M
|
$682.00 M
|
$716.00 M
|
$516.90 M
|
$314.50 M
|
$296.00 M
|
$318.40 M
|
$254.40 M
|
$236.90 M
|
| EBITDA |
$1.49 B |
-$224.00 M |
$866.00 M |
$409.00 M |
$900.00 K |
$471.60 M |
$439.70 M |
$85.80 M |
$232.00 M |
-$22.60 M |
| EBITDA Ratio |
0.34
|
-0.05
|
0.2
|
0.09
|
0
|
0.15
|
0.14
|
0.03
|
0.08
|
-0.01
|
| Operating Income Ratio |
0.06
|
0.07
|
0.09
|
0.06
|
-0.02
|
0.12
|
0.1
|
0.05
|
0.1
|
0
|
| Total Other Income/Expenses Net |
$237.00 M
|
-$1.52 B
|
-$456.00 M
|
-$875.00 M
|
-$595.20 M
|
-$291.80 M
|
-$199.70 M
|
-$375.00 M
|
-$305.60 M
|
-$264.90 M
|
| Income Before Tax |
$488.00 M
|
-$1.20 B
|
-$72.00 M
|
-$571.00 M
|
-$672.00 M
|
$78.20 M
|
$114.10 M
|
-$232.60 M
|
-$22.40 M
|
-$259.50 M
|
| Income Before Tax Ratio |
0.11
|
-0.27
|
-0.02
|
-0.12
|
-0.21
|
0.03
|
0.04
|
-0.08
|
-0.01
|
-0.09
|
| Income Tax Expense |
$150.00 M
|
$36.00 M
|
$6.00 M
|
-$88.00 M
|
-$111.90 M
|
$10.30 M
|
$27.60 M
|
$78.10 M
|
$25.50 M
|
-$48.70 M
|
| Net Income |
$338.00 M
|
-$1.23 B
|
-$78.00 M
|
-$483.00 M
|
-$560.10 M
|
$67.90 M
|
$86.50 M
|
-$310.70 M
|
-$47.90 M
|
-$210.80 M
|
| Net Income Ratio |
0.08
|
-0.28
|
-0.02
|
-0.1
|
-0.17
|
0.02
|
0.03
|
-0.11
|
-0.02
|
-0.07
|
| EPS |
0.68 |
-2.5 |
-0.15 |
-0.97 |
-1.27 |
0.18 |
0.28 |
-0.87 |
-0.13 |
-0.59 |
| EPS Diluted |
0.68 |
-2.5 |
-0.15 |
-0.97 |
-1.27 |
0.18 |
0.28 |
-0.87 |
-0.13 |
-0.59 |
| Weighted Average Shares Out |
$494.00 M
|
$492.30 M
|
$488.30 M
|
$487.20 M
|
$441.40 M
|
$369.00 M
|
$313.70 M
|
$356.20 M
|
$356.20 M
|
$356.20 M
|
| Weighted Average Shares Out Diluted |
$497.30 M
|
$492.30 M
|
$488.30 M
|
$487.20 M
|
$441.40 M
|
$370.30 M
|
$313.70 M
|
$356.20 M
|
$356.20 M
|
$356.20 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
